Vallejo‐Vaz, A. J., Ginsberg, H. N., Davidson, M. H., Eckel, R. H., Cannon, C. P., Lee, L. V., . . . Ray, K. K. (2018). Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials. J Am Heart Assoc.
Citación estilo ChicagoVallejo‐Vaz, Antonio J., et al. "Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials." J Am Heart Assoc 2018.
Cita MLAVallejo‐Vaz, Antonio J., et al. "Lower On‐Treatment Low‐Density Lipoprotein Cholesterol and Major Adverse Cardiovascular Events in Women and Men: Pooled Analysis of 10 ODYSSEY Phase 3 Alirocumab Trials." J Am Heart Assoc 2018.